https://www.med-guidelines.org.uk/index.php?action=history&feed=atom&title=Haemochromatosis 2026-05-04T17:56:51Z Revision history for this page on the wiki MediaWiki 1.34.1 https://www.med-guidelines.org.uk/index.php?title=Haemochromatosis&diff=1916&oldid=prev 2024-05-16T09:19:21Z

<p><span dir="auto"><span class="autocomment">Guidance</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Revision as of 09:19, 16 May 2024</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l12" >Line 12:</td> <td colspan="2" class="diff-lineno">Line 12:</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Guidance==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Guidance==</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Discuss with MO. Acceptable unless evidence of cardiac failure, liver function tests greater than twice upper limit of normal, or pancreatic insufficiency requiring insulin.  </div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Discuss with MO. Acceptable unless evidence of cardiac failure, liver function tests greater than twice upper limit of normal, or pancreatic insufficiency requiring insulin<ins class="diffchange diffchange-inline">.</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">These guidelines only apply in donors with known haemochromatosis. In donors who are newly diagnosed with haemochromatosis during the work-up process, further investigations are needed prior to clearance. Please see [[high ferritin]] for details</ins>.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Pseudonyms or Related Conditions==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Pseudonyms or Related Conditions==</div></td></tr> <!-- diff cache key localdb-mw_:diff::1.12:old-725:rev-1916 --> </table>

Maram.Ghiti@anthonynolan.org https://www.med-guidelines.org.uk/index.php?title=Haemochromatosis&diff=725&oldid=prev 2012-06-19T12:02:56Z

<p>Protected &quot;<a href="/Haemochromatosis" title="Haemochromatosis">Haemochromatosis</a>&quot; (‎[edit=sysop] (indefinite) ‎[move=sysop] (indefinite))</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr class="diff-title" lang="en"> <td colspan="1" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td> <td colspan="1" style="background-color: #fff; color: #222; text-align: center;">Revision as of 12:02, 19 June 2012</td> </tr><tr><td colspan="2" class="diff-notice" lang="en"><div class="mw-diff-empty">(No difference)</div> </td></tr></table>

Dr Robert Lown https://www.med-guidelines.org.uk/index.php?title=Haemochromatosis&diff=236&oldid=prev 2012-06-13T07:28:34Z

<p>Page created</p> <p><b>New page</b></p><div>==Acceptability at Recruitment==<br /> QUALIFIED<br /> <br /> ==Acceptability at CT / Work-Up==<br /> QUALIFIED<br /> <br /> ==Individual at Risk==<br /> Recipient<br /> <br /> ==Explanation of Condition==<br /> Genetic disorder leading to excessive absorption of iron from the gut, which then accumulated in the liver, spleen, heart, pancreas, bone marrow and other organs. The haemochromatosis gene is extremely common in white Northern Europeans (around 1 in 10), and the severity of the condition varies considerably from person to person. <br /> <br /> ==Guidance==<br /> Discuss with MO. Acceptable unless evidence of cardiac failure, liver function tests greater than twice upper limit of normal, or pancreatic insufficiency requiring insulin. <br /> <br /> ==Pseudonyms or Related Conditions==<br /> <br /> <br /> ==Version==<br /> Version 1, Edition 1<br /> <br /> ====Date of Last Update====<br /> 15th June 2012</div>

Dr Robert Lown